Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, AdaptHealth Corp (NASDAQ: AHCO) closed at $9.34 down -0.95% from its previous closing price of $9.43. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 0.97 million shares were traded. AHCO stock price reached its highest trading level at $9.6 during the session, while it also had its lowest trading level at $9.32.
Ratios:
For a deeper understanding of AdaptHealth Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.93. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.14.
Upgrades & Downgrades
In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 22 ’25 when Williams David Solomon III sold 8,200 shares for $9.73 per share. The transaction valued at 79,786 led to the insider holds 50,045 shares of the business.
Rietkerk Shaw bought 32,500 shares of AHCO for $315,250 on Dec 19 ’24. On Dec 10 ’24, another insider, Clemens Jason A, who serves as the Chief Financial Officer of the company, sold 35,000 shares for $9.35 each. As a result, the insider received 327,250 and left with 420,719 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1264863360 and an Enterprise Value of 3068337152. As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.13, and their Forward P/E ratio for the next fiscal year is 9.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.78. Its current Enterprise Value per Revenue stands at 0.943 whereas that against EBITDA is 4.851.
Stock Price History:
The Beta on a monthly basis for AHCO is 1.72, which has changed by -0.029835403 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, AHCO has reached a high of $11.63, while it has fallen to a 52-week low of $7.11. The 50-Day Moving Average of the stock is 0.58%, while the 200-Day Moving Average is calculated to be 0.75%.
Shares Statistics:
For the past three months, AHCO has traded an average of 996.21K shares per day and 1032160 over the past ten days. A total of 135.42M shares are outstanding, with a floating share count of 89.07M. Insiders hold about 34.23% of the company’s shares, while institutions hold 76.50% stake in the company. Shares short for AHCO as of 1763078400 were 9651443 with a Short Ratio of 9.69, compared to 1760486400 on 10040495. Therefore, it implies a Short% of Shares Outstanding of 9651443 and a Short% of Float of 9.3.
Earnings Estimates
Current recommendations for the stock of the company come from 6.0 analysts. The consensus estimate for the next quarter is $0.04, with high estimates of $0.08 and low estimates of -$0.0.
Analysts are recommending an EPS of between $0.78 and $0.65 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $0.99, with 6.0 analysts recommending between $1.23 and $0.81.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $832.51M this quarter.It ranges from a high estimate of $852.5M to a low estimate of $817.63M. As of. The current estimate, AdaptHealth Corp’s year-ago sales were $856.64MFor the next quarter, 8 analysts are estimating revenue of $793.9M. There is a high estimate of $793.9M for the next quarter, whereas the lowest estimate is $793.9M.
A total of 8 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.25B, while the lowest revenue estimate was $3.22B, resulting in an average revenue estimate of $3.23B. In the same quarter a year ago, actual revenue was $3.26BBased on 1 analysts’ estimates, the company’s revenue will be $3.45B in the next fiscal year. The high estimate is $3.45B and the low estimate is $3.45B.
